ProBio Capabilities Update March 2026: Large Molecule

In 2025, a major expansion in New Jersey strengthened domestic capacity for plasmid DNA and viral vector manufacturing, supporting the growing demand for cell and gene therapy development. The newly opened Center of Excellence brings together advanced infrastructure, GMP‑ready production suites, and specialized teams focused on accelerating programs from preclinical stages through regulatory submission.

This video highlights how modern facilities, updated workflows, and integrated development services work together to streamline production for PD and IND‑enabling material. Readers will gain insight into how optimized upstream and downstream processes, digital monitoring systems, and purpose‑built cleanrooms contribute to higher consistency, faster turnaround, and improved readiness for scale‑up.

A guided walkthrough of the manufacturing environment offers a clear view of how operational design supports reliability, regulatory alignment, and efficient tech transfer. Organizations exploring new vectors or preparing for early‑stage clinical milestones will find practical takeaways on how strategic facility design and experienced operational leadership can strengthen development paths and reduce bottlenecks. Access the full showcase to see how these capabilities come together in practice.